Back to Business

Maze Therapeutics CEO Jason Coloma sells $932,259 in Maze shares

Business October 17, 2026 at 11:46 PM

Maze Therapeutics CEO Jason Coloma sells $932,259 in Maze shares

Investing.com

Read the full story at Investing.com

More Stories

U.S. urges Israel to curb settler violence in West Bank, Rubio says

U.S. urges Israel to curb settler violence in West Bank, Rubio says

🇺🇸 Investing.com 37m ago

PagerDuty executive chair Jennifer Tejada sells $1.6 million in shares

PagerDuty executive chair Jennifer Tejada sells $1.6 million in shares

🇺🇸 Investing.com 1h ago

First Guaranty Bancshares director Smith buys $822,013 in stock

First Guaranty Bancshares director Smith buys $822,013 in stock

🇺🇸 Investing.com 1h ago

Your world briefing, in your pocket

Curated news from 12 countries and 10 languages. Coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play